Nomi Health vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Nomi Health provides self-insured employers a direct primary care and benefits platform with transparent pricing, bypassing traditional insurance middlemen to reduce total healthcare spend.
About
Nomi Health operates a direct-to-employer healthcare model that contracts directly with care providers — primary care clinics, labs, imaging centers, and specialists — to offer self-insured employers transparent, pre-negotiated prices without insurance company intermediaries. The platform combines a provider network, benefits administration technology, and care navigation to give employers full visibility into what they are spending and why, replacing opaque managed care contracts with itemized, market-rate pricing.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.